Volume 25, Number 6
by Sei Murakami, Peter Watler, Takashi Ishihara, Shuichi Yamamoto
This article describes advancements in process modeling in biopharmaceutical manufacturing focusing on fermentation and chromatographic separation.
by Mary Ellen Craft
This article describes the use of a technology assessment diagram in the biologics and pharmaceutical industry, and presents the steps to develop, and evaluate the scope options for a facility or process.
by David Paspa
This article presents ways to improve documentation structure incorporating requirements traceability and risk analysis.
This article describes procedures to test gloves, shortcomings of plastic glove behavior, and glove fixation. In addition, it presents a new impulse technique for the improvement of reproducibility and repeatability of a pressure decay test.
by Walfried Laibacher
This article considers the benefits of validating plant access control systems to support consistent product quality and to lift productivity improvement.
by Neal Lewis, David Enke, David Spurlock
This article investigates the staging option to analyze an existing case study that involves the potential licensing of a drug compound that is in development. It demonstrates how options analysis is a useful tool in adding insight to the decision making process when conventional valuation methods are not decisive.
by India Affiliate
This section takes a look at the pharmaceutical industry in India.
This article presents key principles of GxP critical testing including test objectives and business benefits. The final published GAMP® Good Practice Guide may differ from this article as a result of the ISPE external review.
NOTE: Pharmaceutical Engineering article PDF documents are not to be posted on any Web site, blog site or page, or any other internet site without prior permission from ISPE. (Copyright © ISPE. All rights reserved.)